At the tallness of Italy’s lockdown in April, industrial facilities have covered the nation over. In any case, in Piombino Dese, a humble community around 20 miles outside of Venice, the massive glass-cutting machines at the Stevanato Group continued buzzing along, letting out many ampoules and needles. Many representatives wore face masks to work nonstop in three daily shifts, seven days of the week. This made everything from insulin pen cartridges to little glass barrels and — most pressingly — a vast number of minuscule sterile vials, everyone more modest than a solitary liquid ounce, that one day will house portions of a Covid-19 antibody.

When an immunization for Covid is endorsed, the request will be through the rooftop, and for each portion created, a glass vial will be required for bundling. An ongoing Forbes article shed some light on who will make them. The Stevanato Group is a 70+-year-old producer based 20 miles outside of Venice in a modest community called Piombino Dese. The family-claimed business is, as of now, working in three day by day moves, seven days per week to make bundling that goes from insulin pen cartridges (they’re the world’s biggest maker of these) to glass vials for immunizations.

In anticipation of the Covid-19 antibody, Stevanato Group has recruited more than 580 new workers in the top half of 2020 alone. In June, they inked an arrangement with Norway’s Coalition for Epidemic Preparedness and Innovations to flexibly 100 million borosilicate glass vials for up to 2 billion dosages of immunization.